ROSENBLUM MARK J (Exec VP Finance, Interim CFO) purchased 71.4% of their position (5K shares) of DECOY THERAPEUTICS INC. on the open market
Open‑market purchase worth $5.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/18/2020ACC: 0001615219-20-000092
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+5K
Net shares
Net buyer
$5.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$1.00
Trade value
$5K
% of position
71.4%
8/17/2020
7K→12K
Total
Net shares
+5K
Net value
$5K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2020 | P · Purchase | +5K | $1.00 | $5K | 71.4% | 7K | 12K |
| Total | +5K | $5K | ||||||
Derivative Transactions0
No derivative transactions reported